Annual EBIT
-$166.31 M
+$49.19 M+22.83%
December 31, 2023
Summary
- As of February 7, 2025, GOSS annual earnings before interest & taxes is -$166.31 million, with the most recent change of +$49.19 million (+22.83%) on December 31, 2023.
- During the last 3 years, GOSS annual EBIT has risen by +$64.39 million (+27.91%).
- GOSS annual EBIT is now -200268.67% below its all-time high of -$83.00 thousand, reached on December 31, 2016.
Performance
GOSS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$29.20 M
-$85.78 M-151.61%
September 30, 2024
Summary
- As of February 7, 2025, GOSS quarterly earnings before interest & taxes is -$29.20 million, with the most recent change of -$85.78 million (-151.61%) on September 30, 2024.
- Over the past year, GOSS quarterly EBIT has increased by +$15.71 million (+34.98%).
- GOSS quarterly EBIT is now -151.61% below its all-time high of $56.58 million, reached on June 30, 2024.
Performance
GOSS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$56.33 M
+$7.46 M+11.70%
September 30, 2024
Summary
- As of February 7, 2025, GOSS TTM earnings before interest & taxes is -$56.33 million, with the most recent change of +$7.46 million (+11.70%) on September 30, 2024.
- Over the past year, GOSS TTM EBIT has increased by +$109.98 million (+66.13%).
- GOSS TTM EBIT is now -6669.95% below its all-time high of -$832.00 thousand, reached on December 31, 2017.
Performance
GOSS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GOSS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.8% | +35.0% | +66.1% |
| 3 y3 years | +27.9% | +47.3% | +74.8% |
| 5 y5 years | -13.2% | +41.6% | +68.4% |
GOSS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.8% | -151.6% | +47.8% | at high | +73.9% |
| 5 y | 5-year | at high | +27.9% | -151.6% | +54.6% | at high | +75.6% |
| alltime | all time | <-9999.0% | +27.9% | -151.6% | +66.6% | -6669.9% | +75.6% |
Gossamer Bio EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$29.20 M(-151.6%) | -$56.33 M(-11.7%) |
| Jun 2024 | - | $56.58 M(-245.8%) | -$63.79 M(-60.0%) |
| Mar 2024 | - | -$38.80 M(-13.6%) | -$159.44 M(-4.1%) |
| Dec 2023 | -$166.31 M(-22.8%) | -$44.91 M(+22.5%) | -$166.31 M(-4.3%) |
| Sep 2023 | - | -$36.66 M(-6.1%) | -$173.70 M(-10.0%) |
| Jun 2023 | - | -$39.07 M(-14.4%) | -$192.93 M(-6.7%) |
| Mar 2023 | - | -$45.66 M(-12.7%) | -$206.84 M(-4.0%) |
| Dec 2022 | -$215.50 M(+0.4%) | -$52.31 M(-6.4%) | -$215.50 M(+0.4%) |
| Sep 2022 | - | -$55.89 M(+5.5%) | -$214.54 M(+0.2%) |
| Jun 2022 | - | -$52.98 M(-2.5%) | -$214.01 M(-0.9%) |
| Mar 2022 | - | -$54.32 M(+5.8%) | -$216.02 M(+0.7%) |
| Dec 2021 | -$214.56 M | -$51.35 M(-7.2%) | -$214.56 M(-3.8%) |
| Sep 2021 | - | -$55.36 M(+0.7%) | -$223.07 M(+1.0%) |
| Jun 2021 | - | -$55.00 M(+4.0%) | -$220.81 M(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$52.86 M(-11.7%) | -$230.19 M(-0.2%) |
| Dec 2020 | -$230.69 M(+29.3%) | -$59.85 M(+12.7%) | -$230.69 M(+4.5%) |
| Sep 2020 | - | -$53.10 M(-17.5%) | -$220.86 M(+1.4%) |
| Jun 2020 | - | -$64.38 M(+20.6%) | -$217.75 M(+9.6%) |
| Mar 2020 | - | -$53.37 M(+6.7%) | -$198.72 M(+11.4%) |
| Dec 2019 | -$178.37 M(+21.4%) | -$50.02 M(+0.1%) | -$178.37 M(-17.3%) |
| Sep 2019 | - | -$49.99 M(+10.2%) | -$215.78 M(+4.0%) |
| Jun 2019 | - | -$45.35 M(+37.4%) | -$207.56 M(+18.8%) |
| Mar 2019 | - | -$33.02 M(-62.2%) | -$174.75 M(+4.2%) |
| Dec 2018 | -$146.96 M(>+9900.0%) | -$87.43 M(+109.3%) | -$167.77 M(+106.7%) |
| Sep 2018 | - | -$41.76 M(+233.1%) | -$81.17 M(+106.0%) |
| Jun 2018 | - | -$12.54 M(-51.9%) | -$39.41 M(+46.7%) |
| Mar 2018 | - | -$26.04 M(+3029.4%) | -$26.87 M(+3129.4%) |
| Dec 2017 | -$1.15 M(+1289.2%) | -$832.00 K | -$832.00 K |
| Dec 2016 | -$83.00 K | - | - |
FAQ
- What is Gossamer Bio annual earnings before interest & taxes?
- What is the all time high annual EBIT for Gossamer Bio?
- What is Gossamer Bio annual EBIT year-on-year change?
- What is Gossamer Bio quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Gossamer Bio?
- What is Gossamer Bio quarterly EBIT year-on-year change?
- What is Gossamer Bio TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Gossamer Bio?
- What is Gossamer Bio TTM EBIT year-on-year change?
What is Gossamer Bio annual earnings before interest & taxes?
The current annual EBIT of GOSS is -$166.31 M
What is the all time high annual EBIT for Gossamer Bio?
Gossamer Bio all-time high annual earnings before interest & taxes is -$83.00 K
What is Gossamer Bio annual EBIT year-on-year change?
Over the past year, GOSS annual earnings before interest & taxes has changed by +$49.19 M (+22.83%)
What is Gossamer Bio quarterly earnings before interest & taxes?
The current quarterly EBIT of GOSS is -$29.20 M
What is the all time high quarterly EBIT for Gossamer Bio?
Gossamer Bio all-time high quarterly earnings before interest & taxes is $56.58 M
What is Gossamer Bio quarterly EBIT year-on-year change?
Over the past year, GOSS quarterly earnings before interest & taxes has changed by +$15.71 M (+34.98%)
What is Gossamer Bio TTM earnings before interest & taxes?
The current TTM EBIT of GOSS is -$56.33 M
What is the all time high TTM EBIT for Gossamer Bio?
Gossamer Bio all-time high TTM earnings before interest & taxes is -$832.00 K
What is Gossamer Bio TTM EBIT year-on-year change?
Over the past year, GOSS TTM earnings before interest & taxes has changed by +$109.98 M (+66.13%)